Evaluation of immunogenicity-induced DNA vaccines against different SARS-CoV-2 variants.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in 2019 and caused the coronavirus disease 2019 (COVID-19) pandemic worldwide. As of September 2023, the number of confirmed coronavirus cases has reached over 770 million and caused nearly 7 million deaths. The World Health Organi...
Main Authors: | Se Eun Kim, So Hee Park, Woo-Jung Park, Gayeong Kim, Seo Yeon Kim, Hyeran Won, Yun-Ho Hwang, Heeji Lim, Hyeon Guk Kim, You-Jin Kim, Dokeun Kim, Jung-Ah Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2023-01-01
|
Series: | PLoS ONE |
Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0295594&type=printable |
Similar Items
-
Evaluation of immunogenicity-induced DNA vaccines against different SARS-CoV-2 variants
by: Se Eun Kim, et al.
Published: (2023-01-01) -
Immunogenicity and Cross-Protection Efficacy of a Genotype F-Derived Attenuated Virus Vaccine Candidate against Mumps Virus in Mice
by: Seo-Yeon Kim, et al.
Published: (2024-05-01) -
Booster doses of an inactivated F genotype mumps vaccine enhance immunogenicity in mice
by: Seo Yeon Kim, et al.
Published: (2024-03-01) -
Improved Immunogenicity of the Inactivated F Genotype Mumps Vaccine against Diverse Circulating Mumps Viruses in Mice
by: Hyeran Won, et al.
Published: (2023-01-01) -
An inactivated hand-foot-and-mouth disease vaccine using the enterovirus 71 (C4a) strain isolated from a Korean patient induces a strong immunogenic response in mice.
by: Hyun Ju In, et al.
Published: (2017-01-01)